Antineoplastic effect of erbstatin on human mammary and esophageal tumors in athymic nude mice
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (6) , 722-724
- https://doi.org/10.1016/0277-5379(90)90126-e
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomasCancer, 1989
- Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: Relationship to estrogen receptor and lymphatic invasionInternational Journal of Cancer, 1989
- EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCERThe Lancet, 1987
- ANTITUMOR-ACTIVITY OF ERBSTATIN, A TYROSINE PROTEIN-KINASE INHIBITOR1987
- Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.The Journal of Antibiotics, 1986
- PROTEIN-TYROSINE KINASESAnnual Review of Biochemistry, 1985
- Foroxymithine, a new inhibitor of angiotensin-converting enzyme, produced by actinomycetes.The Journal of Antibiotics, 1985
- Growth factors: Mechanism of action and relation to oncogenesCell, 1984
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Purified EGF receptor–kinase interacts specifically with antibodies to Rous sarcoma virus transforming proteinNature, 1981